Dark
Light
System
Security
BIOBLAST PHARMA LTD
BIOBLAST PHARMA LTD. Institutional holdings reported to the SEC.

Institutional Holders (2016Q3)
Portfolio Summary: 15 Institutional holders with a total value of $2,160,000.
#
Manager Name
Shares
Value ($)
%
Options
Notes
1 SABBY MANAGEMENT, LLC 784,057 1,356,000 62.78%
2 Knoll Capital Management, LLC 250,970 424,000 19.63%
3 RENAISSANCE TECHNOLOGIES LLC 84,300 146,000 6.76%
4 OPPENHEIMER & CO INC 42,700 73,000 3.38%
5 HighTower Advisors, LLC 33,500 59,000 2.73%
6 WEDBUSH SECURITIES INC 21,000 36,000 1.67%
7 BlackRock Fund Advisors 16,618 29,000 1.34%
8 CITADEL ADVISORS LLC 11,167 19,000 0.88%
9 UBS Group AG 5,531 10,000 0.46%
10 ACROSPIRE INVESTMENT MANAGEMENT LLC 1,600 3,000 0.14%
11 LADENBURG THALMANN FINANCIAL SERVICES INC. 1,000 2,000 0.09%
12 BlackRock Investment Management, LLC 1,255 2,000 0.09%
13 MORGAN STANLEY 500 1,000 0.05%
14 Tower Research Capital LLC (TRC) 42 0 0.00%
15 HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. 300 0 0.00%

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.